Alpine Biosciences

Cancer is a global epidemic. Killing more than 7 million people annually, virtually all of us have been impacted by it. More than 40 years after launching the war on cancer, the past decade has proven to be the most productive with the introduction of new diagnostics and treatments, including immunotherapy.

Now that scientists have proven that the body’s immune system can be harnessed to treat cancer, newer, more sophisticated approaches are being developed to optimize immunotherapy.

At Alpine Biosciences, our team developed and launched the world’s first cancer immunotherapy. Our goal is to advance this new class of drugs by targeting multiple pathways concurrently to create a more robust, defined, and effective immune response in a more cost-efficient manner.

By achieving this goal, we believe we can accelerate the war on cancer. And at Alpine, we’re committed to that.